1. Abstract 1.1. Background The optimal treatment for the sacrococcygeal pilonidal disease has not been established. Recurrence rates vary by surgical technique. Recurrence wasn’t the only factor in choosing the optimal technique. The procedure should be easy, inexpensive, have few com plications, and allow the patient to return to work or routine
1. Abstract 1.1. Back Ground Herpes zoster, or shingles, is a painful viral infection caused by the reactivation of the varicella-zoster virus (VZV), the same virus as chickenpox, resulting in a blistering rash, often on one side of the body or face, accompanied by burning pain, tingling, and itching.
1. Abstract 1.1. Introduction and Background Renal involvement represents a rare but serious complication of inflammatory bowel diseases (IBD).
1. Abstract 1.1. Introduction Platelet transfusion practices in patients with upper gastrointestinal (UGI) bleeding have traditionally varied, with limited consensus on optimal dosing or thresholds especially for severe cases. Our institution implemented a restrictive, single-unit platelet transfusion policy as part of a broader patient blood management (PBM) initiative.
1. Abstract 1.1. Introduction Hepatitis C Virus (HCV) infection is strongly linked to hepatocellular carcinoma (H.C.C) and also associated with an increased risk of gastric carcinoma, although the connection to stomach cancer is debated, with some studies showing higher risk.
1. Abstract 1.1. Background Liver transplantation (LT) is the definitive therapy for end-stage liver disease and hepatocellular carcinoma (HCC). However, in HBV-endemic regions, the allocation-relevant implications of the viral hepatitis status, waiting time, age, and donor type remain in completely defined in real-world transplant systems.
1. Abstract Overall, early initiation and good tolerance in patients with pancreatitis are correlated with shorter hospital stays compared to late initiation or intolerance.
1. Abstract 1.1. Introduction Gilbert’s syndrome is harmless genetic liver condition where the liver doesn’t process bilirubin efficiently, leading to mild, intermit- tent jaundice and sometimes fatigue or abdominal discomfort.
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.
